THE LATEST WORD

Top Industry Stories – August 6, 2010

Posted on August 6th, 2010 | by Rxmedyn | No Comments »

Health-Care Law Strengthens Medicare Outlook Report Finds

Cuomo Opens Probe Into Healthcare Kickbacks

Some Pharmaceutical Clinical Trial Results are Buried, Study Shows

GSK Signs Dry Powder Deal with Vectura

Some Doctors Try to Profit on Cosmetic Surgery’s Rise

Read the rest of this entry »

Top Industry Stories – August 5, 2010

Posted on August 5th, 2010 | by Rxmedyn | No Comments »

Pregnant Moms Who Overeat Could Make Obese Babies

Genes Hold the Key to Our Heart

Prognosis Guarded for Medicare and Social Security

WebMD Reports Higher Ad Revenues, Site Traffic

Anti Aging Product A Need or A Want?

Read the rest of this entry »

Top Industry Stories – August 4, 2010

Posted on August 4th, 2010 | by Rxmedyn | No Comments »

Lack of Food Puts Kids at Risk for Asthma, Other Chronic Ills

EU Clears Teva’s Ratiopharm Buy With Some Divestments

Obesity Rates Keep Rising, Troubling Health Officials

FDA Moves Toward Tighter Medical Device Oversight

AstraZeneca Said to Pay $55 Million to Settle 5,500 Lawsuits Over Seroquel

Read the rest of this entry »

Top Industry Stories – August 3, 2010

Posted on August 3rd, 2010 | by Rxmedyn | No Comments »

Industry-Paid Studies Likely to Favor Company Drug

Sanofi Makes $0.69 Per Share Bid for Genzyme- Reports

Insurers and Rating Groups Post Information to Help Patients Choose Doctors

Voters Trust Drugs Made in USA, but Few are

Covering New Ground in Health System Shift

Read the rest of this entry »

Top Industry Stories – August 2, 2010

Posted on August 2nd, 2010 | by Rxmedyn | No Comments »

Stem Cell Trial Wins Approval of F.D.A.

US Pharma Fury Over New Moves to Ban Pay-For-Delay Deals

Sanofi May Make Hostile Bid if Genzyme Resists, Citigroup Says

Allergan Beats Street as Botox, Devices on Rebound

Adult Stem Cell Research Far Ahead of Embryonic

Read the rest of this entry »

Top Industry Stories – July 30, 2010

Posted on July 30th, 2010 | by Rxmedyn | No Comments »

Damp House Linked to Kids’ Risk of Nasal Allergies

Novo Nordisk, Lilly, Novartis Said to be Among Bidders for Ascendis Pharma

Novartis Exploits J&J Recall Pains with Triaminic Giveaway

Cuvposa Approved for Chronic Drooling in Children

Story-Telling More Difficult for Brain-Injured Children: Study

Read the rest of this entry »

Top Industry Stories – July 29, 2010

Posted on July 29th, 2010 | by Rxmedyn | No Comments »

Sanofi-Aventis Said to be Likely to Bid $18 Billion for Genzyme

Census Data Reveal Broad Differences Among States in Rates of Uninsured

Bystander CPR – No Breaths Necessary, Studies Say

FDA Considering Changes to Risky Drug Safeguards

Americans Still Confused About Health Reform

Read the rest of this entry »

Top Industry Stories – July 28, 2010

Posted on July 28th, 2010 | by Rxmedyn | No Comments »

FDA Taps Buckmann to Lead Online Drug Comms

Advisory Panel Rebuffs FDA Risk-Mgmt. Plan for Pain Meds

Are Kids’ ER Visits for Food Allergies on the Rise?

New Health Policy: Encouraging Friendships

Merck in Talks for China Partnership

Read the rest of this entry »

Top Industry Stories – July 27, 2010

Posted on July 27th, 2010 | by Rxmedyn | No Comments »

Modest Weight Loss May Curb Urine Leakage

Teva Earnings Climb on Higher U.S. Drug Sales

Genzyme Said to Rebuff Sanofi-Aventis Takeover Approach

Sanofi Looks to Block Generic Lovenox in Court

US Sentte Bill Rejects Ban on Generic Drug Deals

Read the rest of this entry »

Top Industry Stories – July 26, 2010

Posted on July 26th, 2010 | by Rxmedyn | No Comments »

What ‘Clinically Proven’ Means For A Beauty Product

FDA Approves Larger Dose of Pfizer’s Aricept

Sanofi Cuts Outlook After FDA Approves Lovenox Copy

Roche’s Genetech License NovImmune Antibody for Auto-Immune Diseases

Medical Device Problems Hurt 70,000+ Kids Annually

Read the rest of this entry »